Incidence and risk factors for pneumonitis among patients with lung cancer who received immune checkpoint inhibitors after palliative thoracic radiotherapy

相似書籍

• Effect of durvalumab on local control after concurrent chemoradiotherapy for locally advanced non‐small cell lung cancer in comparison with chemoradiotherapy alone
  由: Abe, Takanori, et al.
  出版: (2020)
• Incidence and dose-volume relationship of radiation pneumonitis after concurrent chemoradiotherapy followed by durvalumab for locally advanced non-small cell lung cancer
  由: Saito, Satoshi, et al.
  出版: (2020)
• Stereotactic body radiation therapy using CyberKnife for T1N0M0 lung cancer patients with severe pulmonary dysfunction
  由: Abe, Takanori, et al.
  出版: (2020)
• Results of definitive radiotherapy with concurrent chemotherapy for maxillary sinus carcinomas with neck lymph node metastasis
  由: Abe, Takanori, et al.
  出版: (2020)
• Stereotactic Body Radiotherapy for Pulmonary Oligometastasis from Colorectal Cancer
  由: KOBAYASHI, NAO, et al.
  出版: (2020)